These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9330738)

  • 21. Altering ventricular activation remodels gap junction distribution in canine heart.
    Patel PM; Plotnikov A; Kanagaratnam P; Shvilkin A; Sheehan CT; Xiong W; Danilo P; Rosen MR; Peters NS
    J Cardiovasc Electrophysiol; 2001 May; 12(5):570-7. PubMed ID: 11386519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Wolff-Parkinson-White syndrome: the cellular substrate for conduction in the accessory atrioventricular pathway.
    Peters NS; Rowland E; Bennett JG; Green CR; Anderson RH; Severs NJ
    Eur Heart J; 1994 Jul; 15(7):981-7. PubMed ID: 7925521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disorganization of gap junction distribution in dilated atria of patients with chronic atrial fibrillation.
    Takeuchi S; Akita T; Takagishi Y; Watanabe E; Sasano C; Honjo H; Kodama I
    Circ J; 2006 May; 70(5):575-82. PubMed ID: 16636493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micropatterns of propagation.
    Lee PJ; Pogwizd SM
    Adv Cardiol; 2006; 42():86-106. PubMed ID: 16646586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac myocytes express multiple gap junction proteins.
    Kanter HL; Saffitz JE; Beyer EC
    Circ Res; 1992 Feb; 70(2):438-44. PubMed ID: 1310450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets.
    van der Velden HM; Jongsma HJ
    Cardiovasc Res; 2002 May; 54(2):270-9. PubMed ID: 12062332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue structure and connexin expression of canine pulmonary veins.
    Verheule S; Wilson EE; Arora R; Engle SK; Scott LR; Olgin JE
    Cardiovasc Res; 2002 Sep; 55(4):727-38. PubMed ID: 12176122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Connexins and junctional channels. Roles in the spreading of cardiac electrical excitation and heart development].
    Hervé JC; Derangeon M; Théveniau-Ruissy M; Miquerol L; Sarrouilhe D; Gros D
    Pathol Biol (Paris); 2008 Jul; 56(5):334-41. PubMed ID: 18586407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chronic gap junction conduction-enhancing antiarrhythmic peptide GAP-134 administration on experimental atrial fibrillation in dogs.
    Laurent G; Leong-Poi H; Mangat I; Moe GW; Hu X; So PP; Tarulli E; Ramadeen A; Rossman EI; Hennan JK; Dorian P
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):171-8. PubMed ID: 19808462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac connexins and impulse propagation.
    Jansen JA; van Veen TA; de Bakker JM; van Rijen HV
    J Mol Cell Cardiol; 2010 Jan; 48(1):76-82. PubMed ID: 19729017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conductive bridges in cardiac tissue: a beneficial role or an arrhythmogenic substrate?
    Rudy Y
    Circ Res; 2004 Apr; 94(6):709-11. PubMed ID: 15059940
    [No Abstract]   [Full Text] [Related]  

  • 32. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
    Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology of gap junctions in heart disease.
    Severs NJ
    J Cardiovasc Electrophysiol; 1994 May; 5(5):462-75. PubMed ID: 7519952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological effects of remodeling cardiac gap junctions and cell size: experimental and model studies of normal cardiac growth.
    Spach MS; Heidlage JF; Dolber PC; Barr RC
    Circ Res; 2000 Feb; 86(3):302-11. PubMed ID: 10679482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A map of the heart: gap junctions, connexin diversity and retroviral studies of conduction myocyte lineage.
    Gourdie RG
    Clin Sci (Lond); 1995 Mar; 88(3):257-62. PubMed ID: 7736693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural determinants of slow conduction in the canine sinus node.
    Saffitz JE; Green KG; Schuessler RB
    J Cardiovasc Electrophysiol; 1997 Jul; 8(7):738-44. PubMed ID: 9255681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac conduction abnormalities in mice lacking the gap junction protein connexin40.
    Verheule S; van Batenburg CA; Coenjaerts FE; Kirchhoff S; Willecke K; Jongsma HJ
    J Cardiovasc Electrophysiol; 1999 Oct; 10(10):1380-9. PubMed ID: 10515563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental basis for electrophysiological heterogeneity in the ventricular and outflow tract myocardium as a substrate for life-threatening ventricular arrhythmias.
    Boukens BJ; Christoffels VM; Coronel R; Moorman AF
    Circ Res; 2009 Jan; 104(1):19-31. PubMed ID: 19118284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
    Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
    Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remodeling of ventricular conduction pathways in healed canine infarct border zones.
    Luke RA; Saffitz JE
    J Clin Invest; 1991 May; 87(5):1594-602. PubMed ID: 2022731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.